ES2063406T3 - Procedimiento para la preparacion de analogos de polipeptido intestinal vasoactivo. - Google Patents

Procedimiento para la preparacion de analogos de polipeptido intestinal vasoactivo.

Info

Publication number
ES2063406T3
ES2063406T3 ES91109490T ES91109490T ES2063406T3 ES 2063406 T3 ES2063406 T3 ES 2063406T3 ES 91109490 T ES91109490 T ES 91109490T ES 91109490 T ES91109490 T ES 91109490T ES 2063406 T3 ES2063406 T3 ES 2063406T3
Authority
ES
Spain
Prior art keywords
homoserine
vasoactive intestinal
vip
analogues
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91109490T
Other languages
English (en)
Inventor
Masayasu Sanwa Kagaku K Kurono
Takahiko Sanwa Kagaku K Mitani
Haruo Sanwa Kagaku K Takahashi
Kiichi Sanwa Kagaku Kenk Sawai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2165739A external-priority patent/JPH0459794A/ja
Priority claimed from JP2408425A external-priority patent/JPH04230400A/ja
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Application granted granted Critical
Publication of ES2063406T3 publication Critical patent/ES2063406T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

SE DESCRIBEN ANALOGOS DE POLIPEPTIDO INTESTINAL VASOACTIVO (VIP) Y SU USO . LOS ANALOGOS DE VIP SE MUESTRAN POR LA FORMULA DE DONDE X ES UN RESIDUO DE AMINOACIDO DISTINTO DE METIONINA (MET); E Y ES HOMOSERINA, HOMOSERINA-LACTONA, HOMOSERINA AMIDIZADA, UN RESIDUO DE HOMOSERINA-LACTONA REACCIONADA CON UNA ALQUILAMINA PRIMARIA QUE NO TIENE MAS DE 20 ATOMOS DE CARBON, O UNA CADENA DE POLIPEPTIDO OPCIONAL QUE CONTENGA UNA HOMOSERINA AMIDIZADA EN LA TERMINAL -C. CADA UNO DE LOS ANALOGOS DE VIP SE EMPLEA COMO INGREDIENTE EFECTIVO PARA VARIAS MEDICINAS Y UN TONICO CAPILAR, Y MAS ESPECIALMENTE PARA LA CURACION DEL ASMA Y LA IMPOTENCIA.
ES91109490T 1990-06-26 1991-06-10 Procedimiento para la preparacion de analogos de polipeptido intestinal vasoactivo. Expired - Lifetime ES2063406T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2165739A JPH0459794A (ja) 1990-06-26 1990-06-26 Ｖｉｐ様活性を有するポリペプチド誘導体及びその用途
JP2408425A JPH04230400A (ja) 1990-12-27 1990-12-27 Ｖｉｐ様活性を有するポリペプチド誘導体及びその用途

Publications (1)

Publication Number Publication Date
ES2063406T3 true ES2063406T3 (es) 1995-01-01

Family

ID=26490358

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91109490T Expired - Lifetime ES2063406T3 (es) 1990-06-26 1991-06-10 Procedimiento para la preparacion de analogos de polipeptido intestinal vasoactivo.

Country Status (6)

Country Link
US (1) US5428015A (es)
EP (1) EP0463450B1 (es)
AT (1) ATE101619T1 (es)
DE (1) DE69101187T2 (es)
DK (1) DK0463450T3 (es)
ES (1) ES2063406T3 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
IL99924A (en) * 1991-10-31 1995-12-31 Yeda Res & Dev Derivatives of structurally modified vip and pharmaceutical compositions containing them
US5998368A (en) * 1991-10-31 1999-12-07 Yeda Research And Development Co. Ltd. Derivatives of structurally modified VIP and pharmaceutical compositions containing them
JPH06220090A (ja) * 1993-01-22 1994-08-09 Sanwa Kagaku Kenkyusho Co Ltd ポリペプチド
JPH06306100A (ja) * 1993-04-26 1994-11-01 Sanwa Kagaku Kenkyusho Co Ltd Ｖｉｐアナログ調製用融合蛋白、ｖｉｐアナログの製法並びにそのための遺伝子組換えプラスミド及び形質転換微生物
JPH07173197A (ja) * 1993-12-20 1995-07-11 Sanwa Kagaku Kenkyusho Co Ltd ポリペプチド修飾化合物及びその用途
US5565424A (en) * 1994-02-07 1996-10-15 Ramot - University Authority For Applied Research And Industrial Development Ltd. Superactive VIP antagonists
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
US20020032160A1 (en) * 1995-02-24 2002-03-14 Nyce Jonathan W. Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
WO1996041814A1 (fr) * 1995-06-09 1996-12-27 Itoham Foods Inc. Peptide, bronchodilatateur et agent facilitant l'ecoulement sanguin
IL118003A0 (en) * 1996-04-23 1996-08-04 Yeda Res & Dev Novel vip fragments and pharmaceutical compositions comprising them
US20020099003A1 (en) * 1997-10-28 2002-07-25 Wilson Leland F. Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
US6303575B1 (en) * 1998-05-12 2001-10-16 The Regents Of The University Of California Indolicidin analogs and methods of using same
EP1233811A2 (en) * 1999-11-12 2002-08-28 Leo Rubin Methods for treating cardiac arrest or pulmonary hypertension and compositions for use therein comprising vasoactive intestinal polypeptide and cardiac device for electrical and chemical regulation and methods of use
WO2001060862A1 (en) * 2000-02-18 2001-08-23 Dabur Research Foundation Vasoactive intestinal peptide analogs
ATE355304T1 (de) 2000-02-18 2006-03-15 Dabur Res Foundation Radiomarkierte vip-analoge zur diagnose und therapie
EP1292618B1 (en) * 2000-05-22 2005-10-19 Ramot at Tel Aviv University Ltd. Vip-related peptides for the treatment of sexual disorders in women
GB0016441D0 (en) * 2000-07-04 2000-08-23 Pharmagene Lab Limited Therapeutic method
US6828304B1 (en) 2000-07-31 2004-12-07 Dabur Research Foundation Peptides for treatment of cancer
AU2002220720B2 (en) 2000-11-28 2006-09-14 Mondobiotech Ag Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
GB0118383D0 (en) * 2001-07-27 2001-09-19 Pharmagene Lab Ltd Therapeutic methods
CA2488358A1 (en) 2002-06-10 2003-12-18 Mondobiotech Laboratories Anstalt Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
PL1855661T3 (pl) * 2005-03-07 2011-10-31 Mondobiotech Ag Preparaty zawierające awiptadil
US20080051413A1 (en) * 2006-08-25 2008-02-28 Kaohsiung Medical University Nitrophenylpiperazine derivative of xanthine which relaxes tracheal airway and increases respiratory performance
JP5801807B2 (ja) * 2009-08-14 2015-10-28 フェーズバイオ ファーマシューティカルズ，インコーポレイテッド 修飾された血管作動性腸管ペプチド
ES2669190T3 (es) 2011-06-06 2018-05-24 Phasebio Pharmaceuticals, Inc. Uso de péptidos intestinales vasoactivos modificados en el tratamiento de la hipertensión
WO2015172046A1 (en) 2014-05-08 2015-11-12 Phasebio Pharmaceuticals, Inc. Methods and compositions for treating cystic fibrosis
WO2016130518A2 (en) 2015-02-09 2016-08-18 Phasebio Pharmaceuticals, Inc. Methods and compositions for treating muscle disease and disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880826A (en) * 1971-09-17 1975-04-29 Sami I Said Vasoactive intestinal peptide
JPS56128721A (en) * 1980-03-12 1981-10-08 Eisai Co Ltd Antiallergic agent
JPS6216429A (ja) * 1985-05-14 1987-01-24 アイ・リサ−チ・インステイテユ−ト・オブ・ザ・レテイナ・フアウンデイシヨン 涙液分秘の刺激
GB8525852D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
JPS62246595A (ja) * 1986-04-17 1987-10-27 Eisai Co Ltd 気菅支拡張作用・降圧作用ペプタイド
JP2862870B2 (ja) * 1986-09-12 1999-03-03 協和醗酵工業株式会社 新規ペプチド
JPS63179892A (ja) * 1987-01-19 1988-07-23 Daicel Chem Ind Ltd Ｖｉｐ塩酸塩及びその製造法
JPS6483012A (en) * 1987-09-22 1989-03-28 Eisai Co Ltd Hair growth agent
JPH01296996A (ja) * 1988-05-26 1989-11-30 Akira Kaji 新規ペプチド
IL87055A (en) * 1988-07-08 1994-06-24 Illana Gozes Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
EP0378078A1 (en) * 1989-01-06 1990-07-18 Sanwa Kagaku Kenkyusho Co., Ltd. Motilin-like polypeptide and use thereof

Also Published As

Publication number Publication date
DK0463450T3 (da) 1994-06-27
DE69101187D1 (de) 1994-03-24
EP0463450B1 (en) 1994-02-16
EP0463450A1 (en) 1992-01-02
ATE101619T1 (de) 1994-03-15
US5428015A (en) 1995-06-27
DE69101187T2 (de) 1994-09-29

Similar Documents

Publication Publication Date Title
DK0463450T3 (da) Vasoaktive intestinale polypeptid-analoger og udnyttelsen heraf
ES2076437T3 (es) Analogos de pig y su uso.
DE3683528D1 (de) Tetrapyrrol-therapiemittel.
NL300392I2 (nl) 11beta-gesubstitueerde progesteronanaloga
PT80717B (pt) Processo para a preparacao de analogos de benzodiazepina
BR8906791A (pt) Composicao inseticida; derivado de guanidina e processo para sua preparacao
DE68922405D1 (de) Deletionsanaloga von magaininpeptiden.
EP0552240A4 (en) New method of treating depression
PT95282A (pt) Processo para a prparacao de derivados de n-fenil-pirazol e de composicoes insecticidas que os contem
ATE179169T1 (de) Prostaglandinanaloge
EP0379483A4 (en) 1,2,3,4,10,14b-hexahydrodibenzo c,f¨pyrazino- 1,2-a¨azepino derivatives and 10-aza, 10-oxa and 10-thia analogues
ES528874A0 (es) Procedimiento para la preparacion de nuevos compuestos carboxamidicos de pirrol ortocondensado.
DE69127303D1 (de) Substituierte Triazolopyridazine
ZA88446B (en) Allylmercaptoacetylsydnonimines,processes for their preparation, and their use
IL101708A0 (en) Anti-fattening drugs
BR8208033A (pt) Processo quimico
GR3018765T3 (en) Process for the preparation of N-(2-hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxy-piperidine and of intermediates.
ES2062198T3 (es) Tioureas n,n'-disustituidas y n,n,n'-/n,n',n'-trisustituidas y procedimiento para su preparacion (ii).
ES2058290T3 (es) Analogos de somatostatina terapeuticos.
DE3680725D1 (en) Propanolabkoemmlinge.
IT7969110A0 (it) Procedimento per la preparazione della n ciano n metil n 2 mercapto etil guanidina
YU44164B (en) New industrial process for synthesis of n-/(1|alyl-2|-pyrolidinyle) methyl/-2-metoxy-4,5-azimido-benzamide
ES8703421A1 (es) Procedimiento para preparar derivados de pirrolidindiona.
BR8706887A (pt) Processo para a preparacao de compostos
RO91934B1 (ro) Procedeu de obtinere a n-cloracetil-n-fenil-2,6-dicloranilinei

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 463450

Country of ref document: ES